DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on September 5, 2008; DOI: 10.1124/dmd.108.021311


0090-9556/08/3612-2405-2409$20.00
DMD 36:2405-2409, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.108.021311v1
36/12/2405    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barter, Z. E.
Right arrow Articles by Rostami-Hodjegan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barter, Z. E.
Right arrow Articles by Rostami-Hodjegan, A.
SHORT COMMUNICATION

Covariation of Human Microsomal Protein Per Gram of Liver with Age: Absence of Influence of Operator and Sample Storage May Justify Interlaboratory Data Pooling

Z. E. Barter, J. E. Chowdry, J. R. Harlow, J. E. Snawder, J. C. Lipscomb, and A. Rostami-Hodjegan

Academic Unit of Clinical Pharmacology, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom (Z.E.B., J.E.C., J.R.H., A.R.H.); Simcyp Ltd., Sheffield, United Kingdom (Z.E.B., A.R.H.); U.S. Centers for Disease Control and Prevention/National Institute for Occupational Safety and Health, Cincinnati, Ohio (J.E.S.); and U.S. Environmental Protection Agency, Office of Research and Development, National Centre for Environmental Assessment, Cincinnati, Ohio (J.C.L.)

Scaling of metabolic clearance values from liver microsomal data or recombinantly expressed cytochrome P450 enzymes to predict human hepatic clearance requires knowledge of the amount of microsomal protein per gram of liver (MPPGL). Identification of physiological covariates of MPPGL requires analysis of values from large diverse populations, which necessitates pooling of data from numerous sources. To ensure compatibility between results obtained within and between studies, the impact of interoperator differences and sample storage on values of MPPGL was investigated. With use of triplicate samples from one liver (HL86), no statistically significant difference was detected between values of MPPGL prepared from samples stored at -80°C (23.5 ± 1.2 mg g-1) and those determined using fresh tissue (21.9 ± 0.3 mg g-1). Although there was a significant difference in the yield of microsomal protein obtained from another liver sample (HL43) by three different operators (17 ± 1, 19 ± 2, and 24 ± 1 mg g-1; p = 0.004, analysis of variance), no difference was observed in the estimated MPPGL after application of appropriate correction factors for each operator (28 ± 1, 30 ± 5, and 31 ± 4 mg g-1). The result provided justification for pooling reported values of MPPGL for use in covariate analysis. Investigation of the relationship between age and MPPGL provided preliminary evidence that MPPGL values increase from birth to a maximum of 40 mg g-1 [95% confidence interval for the geometric mean (95% CI meangeo): 37–43 mg g-1 at approximately 28 years followed by a gradual decrease in older age (mean of 29 mg g-1 at 65 years; 95% CI meangeo: 27–32 mg g-1). Accordingly, appropriate age-adjusted scaling factors should be used in extrapolating in vitro clearance values to clinical studies.


Address correspondence to: Dr. Zoe Barter, Floor M, The Royal Hallamshire Hospital, Sheffield S10 2JF, UK. E-mail: z.barter{at}sheffield.ac.uk







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.